搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Schizosaccharomyces pombe Mitochondrial inner membrane organizing system protein PJ691.03 (SPAPJ691.03), partial CSB-YP875747SXV1
CSB-EP875747SXV1
CSB-BP875747SXV1
CSB-MP875747SXV1
CSB-EP875747SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida rugosa Orotidine 5'-phosphate decarboxylase (URA3) CSB-YP875748CCH
CSB-EP875748CCH
CSB-BP875748CCH
CSB-MP875748CCH
CSB-EP875748CCH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans 60S acidic ribosomal protein P1-A (RPP1A) CSB-YP875749CZD
CSB-EP875749CZD
CSB-BP875749CZD
CSB-MP875749CZD
CSB-EP875749CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabinan endo-1,5-alpha-L-arabinosidase A (abnA) CSB-YP875750DOV
CSB-EP875750DOV
CSB-BP875750DOV
CSB-MP875750DOV
CSB-EP875750DOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Orotidine 5'-phosphate decarboxylase (URA3) CSB-YP875751ZAQ
CSB-EP875751ZAQ
CSB-BP875751ZAQ
CSB-MP875751ZAQ
CSB-EP875751ZAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa DNA repair and recombination protein mus-11 (mus-11), partial CSB-YP875752NHA
CSB-EP875752NHA
CSB-BP875752NHA
CSB-MP875752NHA
CSB-EP875752NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized ubiquitin-like protein C800.12c (SPBC800.12c) CSB-YP875753SXV
CSB-EP875753SXV
CSB-BP875753SXV
CSB-MP875753SXV
CSB-EP875753SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Cell cycle transcriptional repressor whi5 (whi5) CSB-YP875754SXV
CSB-EP875754SXV
CSB-BP875754SXV
CSB-MP875754SXV
CSB-EP875754SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe ATP-dependent DNA helicase II subunit 2 (pku80), partial CSB-YP875755SXV
CSB-EP875755SXV
CSB-BP875755SXV
CSB-MP875755SXV
CSB-EP875755SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Meiotically up-regulated gene 20 protein (mug20) CSB-YP875756SXV
CSB-EP875756SXV
CSB-BP875756SXV
CSB-MP875756SXV
CSB-EP875756SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe UPF0494 membrane protein C212.04c (SPAC212.04c), partial CSB-YP875757SXV1
CSB-EP875757SXV1
CSB-BP875757SXV1
CSB-MP875757SXV1
CSB-EP875757SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora sitophila NADP-specific glutamate dehydrogenase (GDH) CSB-YP875758NDAC
CSB-EP875758NDAC
CSB-BP875758NDAC
CSB-MP875758NDAC
CSB-EP875758NDAC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Negative regulator of the PHO system (PHO85) CSB-YP875759CZF
CSB-EP875759CZF
CSB-BP875759CZF
CSB-MP875759CZF
CSB-EP875759CZF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Glucose-6-phosphate isomerase (pgiA), partial CSB-YP875760DPA
CSB-EP875760DPA
CSB-BP875760DPA
CSB-MP875760DPA
CSB-EP875760DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus 50S ribosomal protein L30P (rpl30p) CSB-YP875761FHW
CSB-EP875761FHW
CSB-BP875761FHW
CSB-MP875761FHW
CSB-EP875761FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanosarcina acetivorans Glutamate 5-kinase (proB) CSB-YP875762MFB
CSB-EP875762MFB
CSB-BP875762MFB
CSB-MP875762MFB
CSB-EP875762MFB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis DNA ligase (lig), partial CSB-YP875763FHY
CSB-EP875763FHY
CSB-BP875763FHY
CSB-MP875763FHY
CSB-EP875763FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Arginine--tRNA ligase (argS), partial CSB-YP875764HTM
CSB-EP875764HTM
CSB-BP875764HTM
CSB-MP875764HTM
CSB-EP875764HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Gas vesicle protein GvpN 2 (gvpN2) CSB-YP875765HTM
CSB-EP875765HTM
CSB-BP875765HTM
CSB-MP875765HTM
CSB-EP875765HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Protein gvpF 1 (gvpF11) CSB-YP875766HTM
CSB-EP875766HTM
CSB-BP875766HTM
CSB-MP875766HTM
CSB-EP875766HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>